Autor: "L. Zhang" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases.
Autorzy:: Jiang J; Department of Health Service, Base of Health Service, Air Force Medical University, Xi'an, China.; Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Lu Y; Department of Respiratory and Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, 210009, China. .
Chu J; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China.
Zhang X; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China.
Xu C; Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Liu S; Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Wan Z; Department of Hematology, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Wang J; Basic Medicine School, Air Force Medical University, Xi'an, China.
Zhang L; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China.
Liu K; Department of Health Service, Base of Health Service, Air Force Medical University, Xi'an, China.
Liu Z; Department of Health Service, Base of Health Service, Air Force Medical University, Xi'an, China.
Yang A; State Key Laboratory of Cancer Biology, Department of Immunology, Air Force Medical University, Xi'an, Shaanxi, 710032, China.
Ren X; Department of Respiratory and Critical Care Medicine, Shenzhen General Hospital, Shenzhen University, Shenzhen, China.
Zhang R; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China. .; State Key Laboratory of Cancer Biology, Department of Immunology, Air Force Medical University, Xi'an, Shaanxi, 710032, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Apr 08; Vol. 22 (1), pp. 159. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/therapy
Lung Neoplasms*/metabolism
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Exosomes*/metabolism
Brain Neoplasms*/therapy
Brain Neoplasms*/pathology
Animals ; Humans ; RNA, Small Interfering/pharmacology ; HEK293 Cells ; Cell Line, Tumor ; ErbB Receptors/genetics ; ErbB Receptors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Risk factors and related miRNA phenotypes of chronic pain after thoracoscopic surgery in lung adenocarcinoma patients.
Autorzy:: Zhang L; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Xu L; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Chen Z; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
You H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Hu H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
He H; Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 14; Vol. 19 (3), pp. e0297742. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Lung Neoplasms*/complications
MicroRNAs*/genetics
Chronic Pain*/genetics
Chronic Pain*/complications
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/complications
Humans ; Prospective Studies ; Quality of Life ; Thoracic Surgery, Video-Assisted/adverse effects ; Pain, Postoperative/genetics ; Pain, Postoperative/prevention & control ; Phenotype ; Pneumonectomy/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Study protocol: a core outcome set for perioperative exercise clinical effectiveness trials for lung cancer patients.
Autorzy:: Zhou W; School of Nursing, Anhui Medical University, Hefei, 230032, People's Republic of China.
Zhang Y; School of Nursing, Anhui Medical University, Hefei, 230032, People's Republic of China.
Wang Z; School of Nursing, Anhui Medical University, Hefei, 230032, People's Republic of China.
Zhang L; The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, People's Republic of China.
Zhang X; School of Nursing, Anhui Medical University, Hefei, 230032, People's Republic of China. .; Pokaż więcej
Źródło:: Trials [Trials] 2024 Mar 01; Vol. 25 (1), pp. 157. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/surgery
Humans ; Treatment Outcome ; Delphi Technique ; Endpoint Determination ; Outcome Assessment, Health Care/methods ; Research Design ; Review Literature as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Trends in pain undertreatment among lung cancer patients at the EOL: Analysis of urban city medical insurance data in China.
Autorzy:: Zheng J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Huang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
He J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Zhou H; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Liu T; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Huang J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Shi M; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Zhao Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Fang W; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Yang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.
Zhang L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, People's Republic of China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (9), pp. 693-701. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/complications
Lung Neoplasms*/drug therapy
Insurance*
Humans ; Analgesics, Opioid/therapeutic use ; Undertreatment ; Pain/drug therapy ; Morphine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.
Autorzy:: Chen M; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China.
Zhang S; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Wang F; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
He J; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Jiang W; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China. .
Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 27; Vol. 22 (1), pp. 209. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Urea*/analogs & derivatives
Humans ; Benzimidazoles ; Neoplasm Proteins ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype.
Autorzy:: Ma W; Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Zhou T; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
Song M; Geneplus-Beijing Institute, Beijing, 102206, People's Republic of China.
Liu J; Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Chen G; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
Zhan J; Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Ji L; Geneplus-Beijing Institute, Beijing, 102206, People's Republic of China.
Luo F; Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Gao X; Geneplus-Beijing Institute, Beijing, 102206, People's Republic of China.
Li P; Geneplus-Beijing Institute, Beijing, 102206, People's Republic of China.
Xia X; Geneplus-Beijing Institute, Beijing, 102206, People's Republic of China.
Huang Y; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, People's Republic of China. .
Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 21; Vol. 22 (1), pp. 189. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Small Cell Lung Carcinoma*/genetics
Small Cell Lung Carcinoma*/pathology
Adenocarcinoma*/genetics
Carcinoma, Large Cell*/genetics
Carcinoma, Large Cell*/pathology
Humans ; Microdissection ; Genomics ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer.
Autorzy:: Cheng Y; Department of Oncology, Jilin Cancer Hospital, Changchun, 130000, China. .
Wu C; Department of Oncology, Jilin Cancer Hospital, Changchun, 130000, China.
Wu L; Department of Thoracic Oncology, Hunan Cancer Hospital, Changsha, 410013, China.
Zhao J; Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing, 100142, China.
Zhao Y; Department of Oncology, Henan Cancer Hospital, Zhengzhou, 450003, China.
Chen L; Department of Oncology, Jilin Cancer Hospital, Changchun, 130000, China.
Xin Y; Department of Oncology, Jilin Cancer Hospital, Changchun, 130000, China.
Zhang L; Department of Oncology, Jilin Cancer Hospital, Changchun, 130000, China.
Pan P; Department of Respiratory Disease, Xiangya Hospital Central South University, Changsha, 410008, China.
Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Li J; Department of Oncology, Sichuan Cancer Hospital, Chengdu, 610041, China.
Dong X; Center of Oncology, Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Tang K; Clinical Research Center of Luye Pharma Group Ltd, Luye Life Sciences Group, Beijing, 100080, China.
Gao E; Clinical Research Center of Luye Pharma Group Ltd, Luye Life Sciences Group, Beijing, 100080, China.
Yu F; School of Pharmacy, Yantai University, Yantai, 264005, China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 13; Vol. 14 (1), pp. 3598. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Multicenter Study
MeSH Terms:: Anemia*/etiology
Carbolines*/adverse effects
Heterocyclic Compounds, 4 or More Rings*/adverse effects
Lung Neoplasms*/pathology
Neutropenia*/drug therapy
Small Cell Lung Carcinoma*/pathology
Thrombocytopenia*/etiology
Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; China

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada.
Autorzy:: Grafham GK; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Craddock KJ; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Huang WY; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Louie AV; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Zhang L; MacroStat Inc., Toronto, Ontario, Canada.
Hwang DM; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Parmar A; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology and Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6886. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Retrospective Studies ; Canada ; Molecular Diagnostic Techniques ; Decision Making

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Autorzy:: Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang Z; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hu Y; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Wang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, China.
Yang F; Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhou C; Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhu B; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China.
Ai X; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cao B; Department of Medical Oncology and Radiation Sickness, Cancer Center, Peking University Third Hospital, Beijing, China.
Cao Y; Department of oncology, Kiang Wu Hospital, Macau, China.
Chen M; Department of Thoracic Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chen X; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chu T; Respiratory Department, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Duan J; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhenjiang University School of Medicine, Hangzhou, China.
Feng S; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, China.
Feng W; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan, China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Han C; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
He Y; Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing, China.
Hong S; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Hu J; Shanghai Geriatric Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Huang M; Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Huang Y; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jiang D; Department of Oncology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Jiang R; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Jin B; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, China.
Jin S; National Cancer Center/National Clinical Research Cencer for Cancer/Cancer Hospital &Shenzhen Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Shenzhen, China.
Li J; Department of Medical Oncology, Qilu Hospital of Shandong University, Ji'nan, China.
Li M; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Li Z; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li C; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lin J; Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Liu A; Department of Medical Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Liu SM; Department of Hematology, First Affiliated Hospital, Ji'nan University, Guangzhou, China.
Yutao L; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Z; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Liu Z; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Liu Z; Department of Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.
Liu Z; Department of Thoracic Oncology, Jiangxi Cancer Hospital, Nanchang, China.
Liu Z; Cancer Center, The 10th Affiliated Hospital of Southern Medical University, Dongguan, China.
Lu Y; Department of Abdominal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Ma Z; Department of Respiratory Medicine, Henan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Peng M; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Pu X; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Ren XB; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Shan J; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Zhejiang, China.
Shan J; Department of Medical Oncology, Daping Hospital, Army Medical University, Chongqing, China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Song Z; Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, China.
Su C; Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Sun J; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China.
Tian P; Precision Medicine Key Laboratory of Sichuan Province, Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Wang J; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, China.
Wang F; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang H; Department of Respiratory Medicine, Henan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Wang J; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Wang W; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Wang Y; Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.
Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xie C; Department of Radiation and Medical Oncology, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xie C; Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xin T; Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xu H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu B; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yan X; Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Yu Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Feng Y; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yu Z; Department of Respiratory Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, China.
Yu Y; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yue D; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhang H; Department of Oncology, Guangdong Provicial Hospital of Chinese Medicine, Guangzhou, China.
Zhang H; Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, China.
Zhang T; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Zhang B; Cancer cenrter, Renmin Hospital of Wuhan University, Wuhan, China.
Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department I of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Zhao M; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhong Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Zhou P; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zou J; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zou Z; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (5), pp. 419-426. Date of Electronic Publication: 2024 Jan 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Consensus ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Predicting lung cancer survival prognosis based on the conditional survival bayesian network.
Autorzy:: Zhong L; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. .; Hainan Center for Disease Control and Prevention, Institute for Prevention and Control of Tropical Diseases and Chronic Noninfectious Diseases, Haikou, Hainan, China. .
Yang F; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. .; Institute for Medical Dataology, Shandong University, Jinan, China. .
Sun S; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Wang L; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.; Institute for Medical Dataology, Shandong University, Jinan, China.
Yu H; Chongqing Key Laboratory of Computational Intelligence, Chongqing University of Posts and Telecommunications, Chongqing, China.
Nie X; School of Computer Science and Technology, Shandong Jianzhu University, Jinan, China.
Liu A; Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Xu N; Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Zhang L; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Zhang M; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Qi Y; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Ji H; Department of Thoracic Surgery, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Liu G; Department of Radiology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Zhao H; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, China.
Jiang Y; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Li J; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Song C; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Yu X; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Yang L; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Yu J; Department of Radiology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Feng H; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Guo X; The Department for Chronic and Non-communicable Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, China.
Yang F; Department of Oncology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China. .
Xue F; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. .; Institute for Medical Dataology, Shandong University, Jinan, China. .; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2024 Jan 22; Vol. 24 (1), pp. 16. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/diagnosis
Humans ; Bayes Theorem ; Prognosis ; Calibration ; China/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1.
Autorzy:: Zheng Y; Department of Thoracic Surgery, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, China.
Zhang L; Department of Thoracic Surgery, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, China.
Zhang K; Department of Central Lab, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, China.
Wu S; Department of Hematology and Chemotherapy, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, China.
Wang C; Department of Thoracic Surgery, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, China.
Huang R; Department of Thoracic Surgery, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, China. .
Liao H; Department of Pathology, The Dingli Clinical College of Wenzhou Medical University, Wenzhou Central Hospital, The Second Affiliated Hospital of Shanghai University, Wenzhou, China. .; Pokaż więcej
Źródło:: Biology direct [Biol Direct] 2024 Jan 17; Vol. 19 (1), pp. 7. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Animals ; Mice ; Cisplatin/pharmacology ; Cisplatin/metabolism ; Cisplatin/therapeutic use ; Proto-Oncogene Proteins c-akt/genetics ; Mice, Nude ; Cell Proliferation ; Carcinogenesis/genetics ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Imaging diagnosis and differential diagnosis of extraskeletal osteosarcoma.
Autorzy:: Wang XC; Ganzhou Institute of Medical Imaging, Ganzhou Key Laboratory of Medical Imaging and Artificial Intelligence, Medical Imaging Center, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China.
Zhang L; Ganzhou Institute of Medical Imaging, Ganzhou Key Laboratory of Medical Imaging and Artificial Intelligence, Medical Imaging Center, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China.; Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Lin JB; Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Huang XY; Ganzhou Institute of Medical Imaging, Ganzhou Key Laboratory of Medical Imaging and Artificial Intelligence, Medical Imaging Center, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China.
Liang JH; Ganzhou Institute of Medical Imaging, Ganzhou Key Laboratory of Medical Imaging and Artificial Intelligence, Medical Imaging Center, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China.
Zhong JP; Ganzhou Institute of Medical Imaging, Ganzhou Key Laboratory of Medical Imaging and Artificial Intelligence, Medical Imaging Center, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China.
Peng JD; Ganzhou Institute of Medical Imaging, Ganzhou Key Laboratory of Medical Imaging and Artificial Intelligence, Medical Imaging Center, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China. .
Zhong JY; Ganzhou Institute of Medical Imaging, Ganzhou Key Laboratory of Medical Imaging and Artificial Intelligence, Medical Imaging Center, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 11. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article
MeSH Terms:: Soft Tissue Neoplasms*/pathology
Osteosarcoma*/diagnostic imaging
Osteosarcoma*/pathology
Lung Neoplasms*/diagnostic imaging
Bone Neoplasms*/pathology
Humans ; Male ; Female ; Middle Aged ; Young Adult ; Adult ; Aged ; Diagnosis, Differential ; Margins of Excision ; Retrospective Studies ; Magnetic Resonance Imaging ; Necrosis/diagnosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study.
Autorzy:: Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wu L; The Second Department of Thoracic Oncology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
Zhao J; Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Sun J; Cancer Institute, Xinqiao Hospital, Army Medical University, Chongqing, China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Zhejiang, China.
Zhou J; School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shen Y; Department of Respiratory Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Chen L; Department of Oncology, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, China.
Huang M; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Lin X; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, China.
Liu Z; Department of Medical Oncology, Provincial Clinical College, Fujian Medical University, Fujian provincial hospital, Fuzhou, China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wang Z; Medical Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China.
Wang X; Department of Oncology, Zhongshan Hospital of Xiamen University, Xiamen, China.
Wang H; Department of Respiratory Medicine, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Han Z; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Liu A; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhang H; Department of Oncology, Xijing Hospital, Airforce Military Medical University, Xian, Shanxi, China.
Ye F; Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Gao W; Department of Medical Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Song Z; Department of Clinical Trial, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Chen S; Department of Oncology, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China.
Zhou C; Respiratory Medicine Department, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University Nanjing, Nanjing, Jiangsu, China.
Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wu S; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Wang H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, China.
Yang S; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Li Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chen S; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. .; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, China. .; Interdisciplinary Institute for Medical Engineering, Fuzhou University, Fuzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Dec 16; Vol. 23 (1), pp. 1244. Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; C-Reactive Protein ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Obstructive sleep apnea promotes the progression of lung cancer by modulating cancer cell invasion and cancer-associated fibroblast activation via TGFβ signaling.
Autorzy:: Cui Z; Department of Respiratory Medicine, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Ruan Z; Department of Infectious Disease, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Li M; Department of Respiratory Medicine, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Ren R; Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Ma Y; Pharmacy Management Department, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Zeng J; Department of Laboratory Medicine, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Sun J; Department of Respiratory Medicine, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Ye W; Department of Respiratory Medicine, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Xu W; Department of Respiratory Medicine, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Guo X; Department of Respiratory Medicine, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Xu D; Department of Oncology, Henan Key Laboratory for Precision Medicine in Cancer, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, People's Republic of China.
Zhang L; Department of Nuclear Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.; Pokaż więcej
Źródło:: Redox report : communications in free radical research [Redox Rep] 2023 Dec; Vol. 28 (1), pp. 2279813. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/metabolism
Cancer-Associated Fibroblasts*/metabolism
Cancer-Associated Fibroblasts*/pathology
Sleep Apnea, Obstructive*/metabolism
Sleep Apnea, Obstructive*/pathology
Humans ; Animals ; Mice ; Transforming Growth Factor beta/metabolism ; Neoplasm Invasiveness/pathology ; Hypoxia ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.
Autorzy:: Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Lin G; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Hu Y; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Wang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji'nan, People's Republic of China.
Wang Z; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Yang F; Department of Thoracic Surgery, Peking University People Hospital, Beijing, People's Republic of China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
Zhou C; Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Zhu B; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Ai X; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Cao B; Cancer center, Peking University Third Hospital/ Department of medical oncology and radiation sickness, Peking University Third Hospital, Beijing, People's Republic of China.
Cao Y; Department of oncology, Kiang Wu Hospital, Macau, People's Republic of China.
Chen M; Department of Thoracic Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chen X; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Chu T; Respiratory Department, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Duan J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhenjiang University School of Medicine, Hangzhou, People's Republic of China.
Feng S; Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, People's Republic of China.
Feng W; Department of Pulmonary Oncology, The First People's Hospital of Foshan, Foshan, People's Republic of China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Han C; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.
He Y; Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Hong S; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Hu J; Zhongshan Hospital, Fudan University, Shanghai Geriatric Center, Shanghai, People's Republic of China.
Huang M; Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Huang Y; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Jiang D; Department of Oncology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Jiang K; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Jiang R; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Jin B; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, People's Republic of China.
Jin S; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital &Shenzhen Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Shenzhen, People's Republic of China.
Li J; Department of Medical Oncology, Qilu Hospital of Shandong University, Ji'nan, People's Republic of China.
Li M; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Li Z; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Li C; Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Lin J; Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China.
Liu A; Department of Medical Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Liu SM; Department of Hematology, First Affiliated Hospital, Ji'nan University, Guangzhou, People's Republic of China.
Liu Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Liu Z; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Liu Z; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Liu Z; Department of Oncology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China.
Liu Z; Department of Thoracic Oncology，Jiangxi Cancer Hospital, Nanchang, People's Republic of China.
Liu Z; Cancer Center, The 10th Affiliated Hospital of Southern Medical University, Dongguan, People's Republic of China.
Lu Y; Department of Abdominal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Ma Z; Department of Respiratory Medicine, Henan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Miao Q; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Peng M; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Pu X; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Ren XB; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Shan J; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Zhejiang, People's Republic of China.
Shan J; Department of Medical Oncology, Daping Hospital, Army Medical University, Chongqing, People's Republic of China.
Shen P; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Song Z; Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Su C; Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, People's Republic of China.
Sun J; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China.
Tian P; Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China Hospital, Sichuan University, Precision Medicine Key Laboratory of Sichuan Province, Chengdu, People's Republic of China.
Wang J; Senior Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Wang F; Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Wang H; Department of Respiratory Medicine, Henan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Wang J; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China.
Wang W; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
Wang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Xie C; Department of Radiation and Medical Oncology, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Xie C; Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Xin T; Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Xu H; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Xu Y; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Xu B; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Xu C; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Yan X; Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, People's Republic of China.
Yang Z; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Yu Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Feng Y; Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
Yu Z; Department of Respiratory Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, People's Republic of China.
Yu Y; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Yue D; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Zhang H; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, People's Republic of China.
Zhang H; Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi'an, People's Republic of China.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Zhang L; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhang Q; Institute of Immunotherapy, Fujian Medical University, Fuzhou, People's Republic of China.
Zhang T; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Zhang B; Cancer center, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Zhao J; Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department I of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
Zhao M; Department of Medical Oncology, The First affiliated hospital of China Medical University, Shenyang, People's Republic of China.
Zheng X; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhong F; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Zhou P; State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Zou J; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Zou Z; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, People's Republic of China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Dec; Vol. 14 (34), pp. 3421-3429. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Humans ; Immunotherapy/methods ; Neoadjuvant Therapy ; B7-H1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Micro electrical fields induced MSC-sEVs attenuate neuronal cell apoptosis by activating autophagy via lncRNA MALAT1/miR-22-3p/SIRT1/AMPK axis in spinal cord injury.
Autorzy:: Li K; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Liu Z; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Wu P; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.; Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Chen S; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
Wang M; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
Liu W; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
Zhang L; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
Guo S; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Liu Y; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Liu P; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Zhang B; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Tao L; Department of Orthopaedics, Dehong Hospital of Traditional Chinese Medicine, Dehong, 678400, Yunnan, China.
Ding H; Department of Orthopaedics, Affiliated People's Hospital of Jiangsu University, Zhenjiang, 212002, Jiangsu, China. doctor_.
Qian H; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China. .
Fu Q; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Nov 27; Vol. 21 (1), pp. 451. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Journal Article
MeSH Terms:: RNA, Long Noncoding*/metabolism
Spinal Cord Injuries*/metabolism
Lung Neoplasms*
MicroRNAs*/metabolism
Rats ; Humans ; Animals ; AMP-Activated Protein Kinases ; Sirtuin 1/genetics ; Sirtuin 1/metabolism ; Apoptosis ; Autophagy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis.
Autorzy:: Lu T; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Wang Y; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Liu F; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
Zhang L; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Huang S; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Zhou Y; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
Wu H; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
Mao Y; Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
Jin C; Key Laboratory of Neutronics and Radiation Safety, Chinese Academy of Sciences, Hefei 230031, China.; International Academy of Neutron Science, Qingdao 266199, China.
Song W; Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Nov 27; Vol. 28 (23). Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Berberine*/pharmacology
Berberine*/therapeutic use
Lung Neoplasms*/pathology
Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphatidylinositol 3-Kinase/metabolism ; Reactive Oxygen Species/pharmacology ; Temperature ; Cell Line, Tumor ; Cell Proliferation ; Signal Transduction ; Apoptosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Lnc AC016727.1/BACH1/HIF-1 α signal loop promotes the progression of non-small cell lung cancer.
Autorzy:: Zhang L; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Liang J; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Qin H; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Lv Y; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Liu X; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Li Z; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Chao Z; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Jia C; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Qin X; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China.
Zhang H; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221006, Jiangsu Province, China. .; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, Jiangsu Province, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 10; Vol. 42 (1), pp. 296. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
RNA, Long Noncoding*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Mice ; Humans ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Basic-Leucine Zipper Transcription Factors/genetics ; Basic-Leucine Zipper Transcription Factors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Phyllanthi Tannin Loaded Solid Lipid Nanoparticles for Lung Cancer Therapy: Preparation, Characterization, Pharmacodynamics and Safety Evaluation.
Autorzy:: Wang B; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Wu K; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Liu R; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Huang Y; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Chang Z; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Gao Y; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Liu Y; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Chen H; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Wang Z; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Cui Y; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Wang L; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Ma P; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Zhang L; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Nov 02; Vol. 28 (21). Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/drug therapy
Nanoparticles*/chemistry
Mice ; Animals ; Lipids/chemistry ; Tannins ; Liposomes ; Particle Size ; Drug Carriers/chemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: A novel preoperative image-guided localization for small pulmonary nodule resection using a claw-suture device.
Autorzy:: Wang L; Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, 1111 Jiangnan Road, Ningbo, 315040, Zhejiang, China. .
He J; Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, 1111 Jiangnan Road, Ningbo, 315040, Zhejiang, China.
Zhang L; Department of Respiration, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, 315040, Zhejiang, China.
Chen C; Department of Radiology, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, 315040, Zhejiang, China.
Chen B; Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, 1111 Jiangnan Road, Ningbo, 315040, Zhejiang, China.
Shen W; Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, 1111 Jiangnan Road, Ningbo, 315040, Zhejiang, China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 02; Vol. 13 (1), pp. 18950. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lung Neoplasms*/pathology
Pneumothorax*/etiology
Multiple Pulmonary Nodules*/diagnostic imaging
Multiple Pulmonary Nodules*/surgery
Solitary Pulmonary Nodule*/diagnostic imaging
Solitary Pulmonary Nodule*/surgery
Humans ; Thoracic Surgery, Video-Assisted/methods ; Retrospective Studies ; Hemorrhage/complications

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""L. Zhang"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język